Ending months of uncertainty, French pharma major Sanofi-aventis said on Wednesday it will buy US biotechnology giant Genzyme Corp for more than $20 billion.The proposed deal has been dragging due......
Sanofi-aventis on Mondaysaid it has extended its $18.5 billion offer for Genzyme for the second time, a move that will give the French drug-maker additional time to reach an agreement with US......